(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CELIACARE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CELIACARE

ST13

US500000090647417

Class

5

Filing

90647417

Registration

7367527

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

04/23/2024

Trademark type

Word

Nice classes

5

Filing date

04/15/2021

Registration date

04/23/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/23/2024

Last transaction

04/23/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/13/2023

First use in commerce

11/13/2023

Drawing code

4

Owner type

16

Owner location

BOCA RATON, FL

Examiner

RITTNER, HANNO

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

NEW DAY DIAGNOSTICS LLC
NEW DAY DIAGNOSTICS LLC

Representatives

Stephen P. McNamara ST. ONGE STEWARD JOHNSTON & REENS LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Immunochromatographic test cartridges for clinical testing the presence of antibodies to gluten; medical devicesimmunochromatographic test cartridgesfor clinical testing for anti-tissue transglutaminase IgA antibodies; celiac disease diagnosis and screening testing kits comprised of disinfectant alcohol wipe to disinfect skinlancet for skin puncture to cause bleeding to obtain blood sampleblood collection micropipette to obtain blood sample from lancet sitecontainer of dilution buffer to dilute blood sampleceliac disease test cartridge for receiving diluted blood sample and provide an immunochromatographic test for anti-tissue transglutaminase IgA antibodies in the diluted blood sample; gluten sensitivity and intolerance testing kits comprised of disinfectant wipe to disinfect skinlancet for skin puncture to cause bleeding to obtain blood samplemicropipette to obtain blood sample from lancet sitecontainer of diluent to dilute blood sampleceliac disease test cartridge for receiving diluted blood sample and provide an immunochromatographic test for anti-tissue transglutaminase IgA antibodies in the diluted blood

Publications

History of USPTO decisions and trademark events.

40 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/23/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/23/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/21/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/20/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/17/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/17/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/24/2024

IUAF

USE AMENDMENT FILED

02/23/2024

EISU

TEAS STATEMENT OF USE RECEIVED

02/23/2024

EX3G

SOU EXTENSION 3 GRANTED

02/23/2024

EXT3

SOU EXTENSION 3 FILED

02/23/2024

EEXT

SOU TEAS EXTENSION RECEIVED

02/23/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/11/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/22/2023

EX2G

SOU EXTENSION 2 GRANTED

08/18/2023

EXT2

SOU EXTENSION 2 FILED

08/18/2023

EEXT

SOU TEAS EXTENSION RECEIVED

08/18/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/10/2023

EX1G

SOU EXTENSION 1 GRANTED

01/06/2023

EXT1

SOU EXTENSION 1 FILED

01/06/2023

EEXT

SOU TEAS EXTENSION RECEIVED

01/06/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/23/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/28/2022

PUBO

PUBLISHED FOR OPPOSITION

06/28/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/08/2022

ALIE

ASSIGNED TO LIE

05/20/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/19/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

05/19/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/19/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

05/19/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/19/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/17/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/16/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/16/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/09/2021

GNRT

NON-FINAL ACTION E-MAILED

12/09/2021

CNRT

NON-FINAL ACTION WRITTEN

12/09/2021

DOCK

ASSIGNED TO EXAMINER

12/08/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/22/2021

NWAP

NEW APPLICATION ENTERED

04/19/2021

Continuous trademark protection

Get notified about every new filing that threatens CELIACARE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.